Screener
Bio-Techne TECH Royalty — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Quarter Ended / March 31, 2026 | Quarter Ended / March 31, 2025 | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|---|---|
| Consumables | $257,338 | $257,785 | $724,382 | $719,345 |
| Instruments | 27,664 | 26,111 | 79,095 | 83,185 |
| Services | 21,446 | 27,246 | 71,244 | 81,953 |
| Total product and services revenue, net | $306,448 | $311,142 | $874,721 | $884,483 |
| Royalty revenues | 4,967 | 5,039 | 19,126 | 18,188 |
| Total revenues, net | $311,415 | $316,181 | $893,847 | $902,671 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's royalty — revenue?
- Bio-Techne (TECH) reported royalty — revenue of $4.97M in Q1 2026.
- How has Bio-Techne's royalty — revenue changed year-over-year?
- Bio-Techne's royalty — revenue decreased by 1.4% year-over-year, from $5.04M to $4.97M.
- What is the long-term trend for Bio-Techne's royalty — revenue?
- Over 3 years (2022 to 2025), Bio-Techne's royalty — revenue has grown at a 2.5% compound annual growth rate (CAGR), from $21.98M to $23.69M.
- What does royalty — revenue mean?
- This metric represents the gross revenue generated specifically from royalty-bearing intellectual property licensing agreements, excluding any pass-through taxes. It captures the recurring income stream derived from third-party utilization of the company's proprietary technologies, reagents, or diagnostic methods. This segment serves as a high-margin indicator of the company's ability to monetize its R&D investments through external partnerships.
Ask your AI about Bio-Techne's royalty — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude